Preeclampsia: The role of aldosterone in hypertension and inflammation

Hypertension

Volumn 59, Issue 6, 2012, Pages 1099-1100

  Armanini, Decio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ESTROGEN; MINERALOCORTICOID RECEPTOR; NITRIC OXIDE; PROGESTERONE;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; EDEMA; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTENSION; INFLAMMATION; MONONUCLEAR CELL; NOTE; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 84861526140     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.193011     Document Type: Note

References (8)

1. Macdonald-Wallis C, Lawlor DA, Fraser A, May M, Nelson SM, Tilling K. Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies. Hypertension. 2012;59: 1241-1248.
2. Armanini D, Zennaro MC, Martella L, Scali M, Pratesi C, Grella PV, Mantero F. Mineralocorticoid effector mechanism in preeclampsia. J Clin Endocrinol Metab. 1992;74:948-949.
3. Armanini D, Bordin L Don̂ G, Sabbadin C, Bakdounes L, Ragazzi E, Giorgino F, Fiore C. Polycystic ovary syndrome: implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids. In press.
4. Kim EH, Lim JH, Kim JH, Park YW. The relationship between aldosterone to renin ratio and RI value of the uterine artery in the preeclamptic patients vs normal pregnancy. Yonsei Med J. 2008;49:138-143.
5. Sanchez-Rodriguez EN, Nava-Salazar S, Mendoza-Rodriguez CA, Romero-Arauz F, Moran C, Cerbon MA. Immune endocrine alterations during preeclampsia. Open Neuroendocrinol J. 2010;3:143-151.
6. Armanini D, Strasser T, Weber PC. Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol. 1985;248:E388-E390.
7. Calo L, Zaghetto F, Pagnin E, Davies PA, De Mozzi P, Sartorato P, Martire G Fiore C, Armanini D. Effect of aldosteone and glycyerrhetinic acid on the protein expression of PAI1 and p22phox in human mononuclear leukocytes. J Clin Endocrinol Metab. 2004;89:1973-1976.
8. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction: Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. N Engl J Med. 2003;348: 1309-1321.